UCSF ranked at the top in a national evaluation of residency training programs by the online physician network Doximity and U.S. News & World Report.
September 14, 2014
March 24, 2014
According to authors Rita Redberg, MD, UCSF professor of medicine, and UCSF second-year medical student Sarah Zheng, the U.S. Food and Drug Administration (FDA) should require that clinical data be submitted as part of a more rigorous re-evaluation of medical devices that are modified after approval.
February 03, 2014
A new study led by researchers from UCSF Benioff Children’s Hospital is the first to evaluate whether purified cannabinoid is effective in treating severe forms of childhood epilepsy.
July 18, 2013
UCSF researchers have found a way to knock down cancers caused by a tumor-driving protein called “myc,” paving the way for patients with myc-driven cancers to enroll in clinical trials for experimental treatments.
June 26, 2013
A UCSF-led team has created a set of guidelines for doctors and other clinicians to use for communicating uncertain prognoses to elderly patients and those battling terminal illness.
March 21, 2013
UCSF has named a highly accomplished pharmacist and clinical scientist, B. Joseph Guglielmo, PharmD, a 34-year member of the UCSF faculty, to lead the nation’s premier School of Pharmacy.
March 06, 2013
The Agency for Healthcare Research and Quality (AHRQ) has released a new report that identifies the top 10, evidence-based patient safety strategies available to clinicians.
January 11, 2013
UCSF ranks second in the annual ranking of world universities in clinical medicine and pharmacy by the Academic Ranking of World Universities (ARWU).
December 17, 2012
Drugs and medical devices tend to appear more beneficial in scientific papers if they were manufactured by the company that sponsored the study, showing that who pays for the clinical trial has a direct impact on the reported outcome, according to a new analysis by researchers at UCSF and the Cochrane Collaboration.
June 29, 2012
As Thursday’s Supreme Court ruling on the health care law is examined, experts are citing concerns about the Medicaid decision, which could end up insuring fewer Americans as states opt out of expansion.